44 results on '"Sanchez-Luceros A"'
Search Results
2. Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor
3. Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians’ survey—communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis
4. Examining international practices in the management of pregnant women with von Willebrand disease
5. Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial
6. Prevalence of Fabry Disease in Young Patients with Stroke in Argentina
7. PB0848 Differences between Collagen-6 Binding and Collagen-1 Binding in Type-2 VWD (Preliminary Study)
8. PB0330 Relevance of ADAMTS13 Antigenic Levels in the Characterization of Pathological Mechanisms Associated with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP)
9. PB0313 Towards the Standardisation of ADAMTS-13 Antibody Testing in Thrombotic Thrombocytopenic Purpura (TTP)-Results of the IMATAS Collaborative Study
10. Marked bleeding diathesis in patients with platelet dysfunction due to a novel mutation in RASGRP2, encoding CalDAG-GEFI (p.Gly305Asp)
11. Von Willebrand disease type 2M: Correlation between genotype and phenotype: Comment from Woods et al.
12. Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation
13. Von Willebrand disease type 2M: Correlation between genotype and phenotype: Comment from Woods et al
14. Type 2N von Willebrand disease: Is it always a recessive trait?
15. Identification of a novel polymorphism in P.N258 of the GP1BA gene: VWF11
16. Identification of p.W246L As a Novel Mutation in the GP1BA Gene Responsible for Platelet-Type von Willebrand Disease
17. Human umbilical vein endothelial cells, platelets and human tumor cell lines express isoforms 2 and 3 of ADAMTS13: PB 3.33–3
18. C1272F: a novel type 2A von Willebrandʼs disease mutation in A1 domain; its clinical significance
19. P0097IDENTIFICATION OF TWO NOVELS SINGLE NUCLEOTIDE VARIANTS OF THE COMPLEMENT GENES IN A PATIENT WITH THE ASSOCIATION OF PREGNANCY ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY
20. Major hemorrhage related to surgery in patients with type 2A von Willebrand disease: 35P53
21. C1272f: a novel type 2A von Willebrand disease mutation in A1 domain: 35P52
22. Acquired factor X (FX) deficiency, chronic lymphocytic leukaemia (CLL) and amyloidosis (A): PC-047
23. Pregnancy in subtype 2B VWD: 30 PO 906
24. Morbidity of lupus anticoagulants in children: a single institution experience
25. Combined effects of two mutations in von Willebrand disease 2M phenotype
26. Marked bleeding diathesis in patients with platelet dysfunction due to a novel mutation in RASGRP2, encoding CalDAG-GEFI (p.Gly305Asp)
27. Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation
28. Argentinean Initiative of Stroke in the Young and Fabry Disease (FD): Final Results (I2.012)
29. Argentinean Initiative of Stroke in the Young and Fabry Disease (FD): Final Results (P3.229)
30. C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significance
31. Abstract P6-11-07: Perioperative administration of desmopressin (dDAVP) in breast cancer patients: A phase II dose-escalation study
32. C0379 Several polymorphisms in the ADAMTS13 gene in a patient with thrombotic thrombocytopenic purpura (TTP)
33. Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis
34. C1272F: a novel type 2A von Willebrand’s disease mutation in A1 domain; its clinical significance
35. Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history
36. Antiphospholipid antibodies and hyperhomocysteinaemia in patients with vascular occlusive disease
37. Patients’ perceptions regarding oral anticoagulation therapy and its effect on quality of life
38. C0184: Lupus Anticoagulant in Patients without Thrombotic or Obstetric Complications
39. C0198: Genotypes of VKORC-1 and Sensitivity to Oral Anticoagulants in Pediatric Population
40. Effect of Low-Dose Aspirin on the International Normalized Ratio Variability in Patients with Mechanical Heart Valve Prostheses
41. Marked bleeding diathesis in patients with platelet dysfunction due to a novel mutation in RASGRP2 , encoding CalDAG-GEFI (p.Gly305Asp).
42. Acquired Hemophilia A. Experience Of a Single Center
43. Antiphospholipid antibodies and hyperhomocysteinaemia in patients with vascular occlusive disease
44. Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: A retrospective analysis by a single institution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.